Rocket


News + Filings
Transactions





Schwab Andrew J.

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
08/18/2023Skye Bioscience, Inc.NMUSGrantWarrant (Right to Buy)426.3M$0.02$8.8MBy 5AM Ventures VII, L.P.08/18/2023
08/18/2023Skye Bioscience, Inc.NMUSGrantCommon Stock267.6M$0.00$0By 5AM Ventures II, L.P.08/18/2023
08/18/2023Skye Bioscience, Inc.NMUSGrantCommon Stock10.6M$0.00$0By 5AM Co-Investors II, L.P.08/18/2023
08/18/2023Skye Bioscience, Inc.NMUSGrantCommon Stock684.4M$0.01$7MBy 5AM Ventures VII, L.P.08/18/2023
08/18/2023Skye Bioscience, Inc.NMUSGrantCommon Stock161.9M$0.01$1.7MBy 5AM Ventures II, L.P.08/18/2023
08/18/2023Skye Bioscience, Inc.NMUSGrantCommon Stock6.4M$0.01$65.8kBy 5AM Co-Investors II, L.P.08/18/2023
02/23/2023Enliven Therapeutics, Inc.IMRAGrantCommon Stock960.4k$0.00$0See footnote02/23/2023
02/23/2023Enliven Therapeutics, Inc.IMRAGrantCommon Stock4.8M$0.00$0See footnote02/23/2023
12/03/2021Pear Therapeutics, Inc. GrantClass A Common Stock3.2M$0.00$0by 5AM Opportunities I, L.P.12/03/2021
12/03/2021Pear Therapeutics, Inc. GrantClass A Common Stock610.4k$0.00$0by 5AM Co-Investors IV, L.P.12/03/2021
12/03/2021Pear Therapeutics, Inc. GrantClass A Common Stock200k$10.00$2Mby 5AM Opportunities I, L.P.12/03/2021
12/03/2021Pear Therapeutics, Inc. GrantClass A Common Stock14.6M$0.00$0by 5AM Ventures IV, L.P.12/03/2021
11/30/20205:01 Acquisition Corp. Other (disposition)Class B Common Stock235.9k$0.00$0See Footnote11/30/2020
11/17/20205:01 Acquisition Corp. Other (disposition)Class B Common Stock30k$0.00$0See Footnote11/17/2020
11/12/20205:01 Acquisition Corp. Other (acquisition)Class A Common Stock5.1k$10.00$51.3kSee Footnote11/12/2020
10/16/20205:01 Acquisition Corp. Other (disposition)Class B Common Stock90k$0.00$0See Footnote10/16/2020
10/16/20205:01 Acquisition Corp. Other (acquisition)Class A Common Stock360k$10.00$3.6MSee Footnote10/16/2020
05/26/2020scPharmaceuticals Inc.SCPHPurchaseCommon Stock578k$8.65$5MBy 5AM Opportunities I, L.P.05/26/2020

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy